Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Dual RNA-seq of Mtb-infected macrophages in vivo reveals ontologically distinct host-pathogen interactions
BPC-157 enhances cellular proliferation and migration, while GHK-Cu supports the structural integrity of the tissue by stimulating extracellular matrix production
Some patients have reported anxiety during treatment
In 2025, the company reported a solid +8.62% YoY revenue growth, supported by its oncology franchise: Tagrisso ($7.25B) continues to lead in lung cancer with strong global adoption, Imfinzi ($6.06B) is expanding across multiple cancer indications, and Calquence ($3.51B) is gaining traction in hematologic cancers - reflecting sustained momentum in its cancer portfolio
US$ 24.28
US$ 28.67
US$ 24.06
US$ 24.89
US$ 23.90
